HOXB7 and breast carcinoma: In another breast cancer cell line, MCF7, which represents the Luminal A molecular subtype, HOXB7 overexpression renders cells resistant to tamoxifen via cross-talk between receptor tyrosine kinases and ERα signaling [19].